Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Dugo, Matteo"'
Autor:
Sommariva M; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy. michele.sommariva@unimi.it.; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy. michele.sommariva@unimi.it., Dolci M; Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy., Triulzi T; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy., Ambrogi F; Dipartimento di Scienze Cliniche e di Comunità, Università degli Studi di Milano, Via Celoria 22, 20133, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Via Olgettina 60, 20132, Milan, Italy., De Cecco L; Integrated Biology of Rare Tumors, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy., Le Noci V; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Bernardo G; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Anselmi M; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Montanari E; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Pupa SM; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy., Signorini L; Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy., Gagliano N; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy., Sfondrini L; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Via Mangiagalli 31, 20133, Milan, Italy.; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy., Delbue S; Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Via Pascal 36, 20133, Milan, Italy., Tagliabue E; Microambiente e Biomarcatori dei Tumori Solidi, Dipartimento di Oncologia Sperimentale, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Amadeo 42, 20133, Milan, Italy.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jun 07; Vol. 14 (1), pp. 13134. Date of Electronic Publication: 2024 Jun 07.
Autor:
Licata L; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Barreca M; University of Milano-Bicocca, Milan, Italy., Galbardi B; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Dugo M; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Viale G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy., Győrffy B; Department of Bioinformatics, Semmelweis University, Budapest, Hungary.; Cancer Biomarker Research Group, Research Centre for Natural Sciences, Budapest, Hungary., Karn T; Goethe University Hospital Frankfurt, Frankfurt, Germany., Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Gianni L; Michelangelo Foundation, Milan, Italy., Callari M; Michelangelo Foundation, Milan, Italy. maurizio.callari@fondazionemichelangelo.org., Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan, Italy. bianchini.giampaolo@hsr.it.; School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy. bianchini.giampaolo@hsr.it.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Dec; Vol. 129 (12), pp. 2025-2033. Date of Electronic Publication: 2023 Nov 07.
Autor:
Ligorio F; Metabolic Reprogramming in Solid Tumors Unit, IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Cosimo S; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Ciniselli CM; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pizzamiglio S; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Castagnoli L; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy., Galbardi B; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Loi S; Sir Peter MacCallum Cancer Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Michiels S; Department of Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Triulzi T; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., El-Abed S; Breast International Group (BIG), Brussels, Belgium., Izquierdo M; Novartis Pharma AG, Basel, Switzerland., de Azambuja E; Department of Medical Oncology, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Bruxelles, Belgium., Nuciforo P; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Huober J; Breast Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland., Moscetti L; Department of Oncology-Hematology, University Hospital of Modena, Modena, Italy.; Gruppo Oncologico Italiano per la Ricerca Clinica, Parma, Italy., Janni W; Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany., Coccia-Portugal MA; Clinical Trial Department, Eastleigh Breast Care Center, Pretoria, South Africa., Corsetto PA; Department of Pharmacology and Biomolecular Science, University of Milan, Milan, Italy., Belfiore A; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lorenzini D; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Daidone MG; Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vingiani A; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy., Pupa SM; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchini G; Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy.; Breast Cancer Unit - Department of Medical Oncology, Università Vita-Salute San Raffaele, Milan, Italy., Pruneri G; Pathology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology and Hemato-Oncology Department, University of Milan, Milan, Italy., Vernieri C; Metabolic Reprogramming in Solid Tumors Unit, IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Dec 08; Vol. 114 (12), pp. 1720-1727.
Autor:
Triulzi T; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Di Cosimo S; DRAST, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pienkowski T; Oncology and Breast Diseases Department, Postgraduate Medical Education Center, Warsaw, Poland., Im YH; Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea., Bianchi GV; Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., De Cecco L; DRAST, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tseng LM; Taipei-Veterans General Hospital, National Yang-Ming University, Taiwan., Liu MC; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan., Bermejo B; Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia, Spain., Semiglazov V; NN Petrov Research Institute of Oncology, St Petersburg, Russia., Viale G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., de la Haba-Rodriguez J; Hospital Reina Sofia, Córdoba, Spain., Oh DY; Division of Medical Oncology, Seoul National University Hospital Cancer Research Institute, Seoul National University College of Medicine, Republic of Korea., Poirier B; Centre des Maladies du sein, Hôpital du Saint-Sacrement, CHU de Québec, Canada., Valagussa P; Fondazione Michelangelo, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy.; Fondazione Gianni Bonadonna, Milan, Italy., Tagliabue E; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Jun; Vol. 16 (12), pp. 2355-2366. Date of Electronic Publication: 2021 Dec 17.
Autor:
Viganò L; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Locatelli A; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Ulisse A; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Galbardi B; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Tosi D; Institut régional du Cancer de Montpellier (ICM), Montpellier, France., Tacchetti C; Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan, Italy., Daniele T; Experimental Imaging Centre, IRCCS San Raffaele Scientific Institute, Milan, Italy., Győrffy B; Department of Bioinformatics, Faculty of General Medicine, Semmelweis University, Budapest, Hungary.; 2nd Dept. of Pediatrics, Faculty of Medicine, Semmelweis University, Budapest, Hungary.; TTK Oncology Biomarker Research Group, Institute of Enzymology, Budapest, Hungary., Sica L; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Macchini M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Zambetti M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Zambelli S; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Bianchini G; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Gianni L; Fondazione Michelangelo, Milan, Italy.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 May 13; Vol. 28 (10), pp. 2167-2179.
Autor:
Fina E; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy. emanuela.fina@humanitasresearch.it.; Current affiliation: Humanitas Research Center, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, 20089, Milan, Italy. emanuela.fina@humanitasresearch.it., Cleris L; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.; Current affiliation: Department of Medical Oncology, IRCCS Ospedale San Raffaele, via Olgettina 60, 20132, Milan, Italy., Lecchi M; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Ciniselli CM; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Lecis D; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Bianchi GV; Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Verderio P; Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy., Daidone MG; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy., Cappelletti V; Biomarkers Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133, Milan, Italy. vera.cappelletti@istitutotumori.mi.it.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2022 Feb 25; Vol. 41 (1), pp. 78. Date of Electronic Publication: 2022 Feb 25.
Autor:
Guardia C; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Arpí-LLucià O; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Menendez S; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Casadevall D; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Servitja S; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Montero JC; Centro de Investigación del Cáncer, IBSAL-CSIC-CIBERONC, Salamanca, Spain., Soria-Jiménez L; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Sabbaghi M; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Peña R; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain., Madoz-Gúrpide J; Department of Pathology, IIS-Fundación Jiménez Díaz-CIBERONC, Madrid, Spain., Lloveras B; Department of Pathology, Hospital del Mar, Barcelona, Spain., Lluch A; INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia-CIBERONC, Universitat de València, Barcelona, Spain., Eroles P; INCLIVA Biomedical Research Institute, Hospital Clínico de Valencia-CIBERONC, Universitat de València, Barcelona, Spain.; INCLIVA, Biomedical Research Institute, Valencia, Spain., Arribas J; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Preclinical Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Pandiella A; Centro de Investigación del Cáncer, IBSAL-CSIC-CIBERONC, Salamanca, Spain., Gianni L; Fondazione Gianni Bonadonna, Milan, Italy., Rojo F; Department of Pathology, IIS-Fundación Jiménez Díaz-CIBERONC, Madrid, Spain., Rovira A; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain., Albanell J; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. jalbanell@hospitaldelmar.cat.; Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 15; Vol. 27 (18), pp. 5096-5108. Date of Electronic Publication: 2021 Aug 12.
Autor:
Majorini MT; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Rigoni A; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Botti L; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Triulzi T; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., De Cecco L; Platform of Integrated Biology, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Fontanella E; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Jachetti E; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. daniele.lecis@istitutotumori.mi.it mariopaolo.colombo@istitutotumori.mi.it., Lecis D; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. daniele.lecis@istitutotumori.mi.it mariopaolo.colombo@istitutotumori.mi.it.
Publikováno v:
Cancer research [Cancer Res] 2020 Jun 01; Vol. 80 (11), pp. 2311-2324. Date of Electronic Publication: 2020 Mar 16.
Autor:
Chiodoni C; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Renzi TA; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Perrone M; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tomirotti AM; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sangaletti S; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Botti L; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Dugo M; Platform of Integrated Biology - Bioinformatics, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy., Milani M; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bongiovanni L; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Marrale M; Department of Physics and Chemistry, University of Palermo, Palermo, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy., Colombo MP; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. mariopaolo.colombo@istitutotumori.mi.it.
Publikováno v:
Cancer research [Cancer Res] 2020 Feb 01; Vol. 80 (3), pp. 484-498. Date of Electronic Publication: 2019 Nov 27.
Autor:
Castagnoli L; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Iorio E; Core Facilities, NMR Unit, Istituto Superiore di Sanità, Roma, Italy., Dugo M; Functional Genomics and Bioinformatics Core Facility, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale deiTumori, Milan, Italy., Koschorke A; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Faraci S; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Canese R; Core Facilities, NMR Unit, Istituto Superiore di Sanità, Roma, Italy., Casalini P; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Nanni P; Laboratory of Immunology and Biology of Metastasis, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy., Vernieri C; IFOM, FIRC Institute of Molecular Oncology, Milan, Italy.; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Nicola M; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Morelli D; Laboratory Medicine Unit, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tagliabue E; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pupa SM; Molecular Targeting Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Journal of cellular physiology [J Cell Physiol] 2019 Feb; Vol. 234 (2), pp. 1768-1779. Date of Electronic Publication: 2018 Aug 21.